According to data and analytics company, GlobalData, personalised medicine is becoming an increasing possibility for patients as a result of newly developed algorithms and the use of big data.
A survey from The Pistoia Alliance has revealed that nearly three-quarters (72%) of life science professionals believe their industry is behind the curve in the development of artificial intelligence (AI).
As the race to dominate the artificial intelligence (AI) space steps up a gear, I take a look at how AI finds use in pharma and how different regions plan to invest in this exciting area.
New research from Oracle Health Services in partnership with Informa Engage/Pharma Intelligence has revealed that more than 60% of drug safety experts are planning to use artificial intelligence (AI) to improve the speed and security
In this online exclusive, Sean Riley, global industry director for manufacturing and transportation at Software AG discusses five manufacturing trends that are expected in 2018.
In this online exclusive, Stuart Ward, head of Business Analysis at R&D software provider, IDBS, looks at some of the important aspects of laboratory automation that need to be considered to maintain regulatory compliance.
Head of operations at Sharp Clinical Services, Dave Wilson, reveals how automating packaging lines can benefit clinical trial supply and what should be considered before introducing new technology.
Exscientia and GlaxoSmithKline (GSK) have entered into a strategic collaboration to apply an AI-enabled platform in the discovery of novel and selective small molecules for up to 10 disease-related targets.
Biopharmaceutical company, AstraZeneca has unveiled its NiCola-B drug discovery robot, capable of performing industrial scale experiments in the search for new, life-saving medicines.
